About
Bio
Impact Factor:
2.094 (Source: 2015 Thomson Reuters, Journal Citation Reports).
Journal Ranking:
150/213 (Oncology) - (Source: Publisher)
Circulation:
The Publisher does not disclose the circulation.
Aims of the Journal:
Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines.
Content:
Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:
- Expert Commentary: a personal view on the most effective or promising strategies
- Five-year view: a clear perspective of future prospects within a realistic time-scale
- Key issues: an executive summary cutting to the author's most critical points
Readership:
The journal is aimed at doctors and Health professionals working in Oncology mainly.
Manuscript Submission:
Articles published in the journal are commissioned by the Editor in collaboration with the Editorial Advisory Board. All articles are subject to rigorous peer-review.
Author guidelines can be found here.
Online manuscripts submission can be found here.
Ad Rates:
Advertising information can be found here.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Oncology
Bio
Impact Factor: 2.094 (Source: 2015 Thomson Reuters, Journal Citation Reports). Journal Ranking: 150/213 (Oncology) - (Source: Publisher) Circulation: The Publisher does not disclose the circulation. Aims of the Journal: Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. Content: Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: - Expert Commentary: a personal view on the most effective or promising strategies - Five-year view: a clear perspective of future prospects within a realistic time-scale - Key issues: an executive summary cutting to the author's most critical points Readership: The journal is aimed at doctors and Health professionals working in Oncology mainly. Manuscript Submission: Articles published in the journal are commissioned by the Editor in collaboration with the Editorial Advisory Board. All articles are subject to rigorous peer-review. Author guidelines can be found here. Online manuscripts submission can be found here. Ad Rates: Advertising information can be found here.
Website
Social media
Location
Frequency
Circulation
Sectors
Oncology
Most recent articles by Expert Review of Anticancer Therapy
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Expert Review of Anticancer Therapy
-
OncologyLive
Established in 2000 as Oncology Net Guide and rebranded in March 2011 as OncLive. Written for physicians to enable them to keep up to date with the rapidly expanding amount of medical information and resources on oncology. Designed as a handbook for frequent referencing and written in an easy-to-understand style. Articles are quick-reading, timely, provides practical information and information about new medical treatments. Media Alert: Tuesday April 12th 2011 Oncology Net Guide has changed its name to OncLive. Anita Shaffer is Associate Editor in charge of the oncology research and technology magazine. She may be reached at +1 (609) 716 7777 Ext 192 and ashaffer@onclive.com
ViewMedical News TodayBackground and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.
ViewTargeted OncologyTargeted Oncology is an online resource for oncology news and research, carrying content from Intellisphere's printed oncology journals, Targeted Therapies and The Journal of Targeted Therapies.
ViewJAMA OncologySet to launch in February 2015, this medical journal aimed at physicians covers oncology. Will feature all aspects of medical, radiation, and surgical oncology and its subspecialties
ViewASH Clinical NewsASH Clinical News is a news publication from the American Society of Hematology and serves as a source for worldwide news and perspectives on hematology and oncology. Coverage includes blood disorders and related topics of interest to hematologists, including developments in oncology, endocrinology and cardiology. Each month it provides the latest updates in the field along with perspectives and opinions from key leaders as well as tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.
ViewUse CisionOne to find more relevant outletsContact Expert Review of Anticancer Therapy and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.